Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

9.9%

77 terminated/withdrawn out of 774 trials

Success Rate

89.4%

+2.9% vs industry average

Late-Stage Pipeline

33%

259 trials in Phase 3/4

Results Transparency

60%

390 of 650 completed trials have results

Key Signals

19 recruiting390 with results48 terminated29 withdrawn

Enrollment Performance

Analytics

N/A

365(51.8%)

Phase 4

148(21.0%)

Phase 3

111(15.7%)

Phase 2

64(9.1%)

Phase 1

17(2.4%)

705Total

N/A(365)

Phase 4(148)

Phase 3(111)

Phase 2(64)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (774)

Showing 20 of 774 trials

NCT07238699Not ApplicableCompleted

An Evaluation of the Safety and Tolerability of Ocular Lubricants

Role: lead

NCT07243275Phase 4Completed

SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease

Role: collaborator

NCT07484191Not ApplicableActive Not Recruiting

Contralateral Claims Study of Clareon Vivity Pro

Role: lead

NCT06285695Not ApplicableCompleted

Clareon Toric Study (T2-T9)

Role: lead

NCT04553523Not ApplicableRecruiting

Hydrus® Microstent New Enrollment Post-Approval Study

Role: lead

NCT06784063Not ApplicableCompleted

Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs)

Role: lead

NCT05827133Completed

Effect of Intraocular Lens (IOL) Centration and Tilt on Visual Performance With Clareon® Vivity® IOL Implantation

Role: collaborator

NCT07587138Not ApplicableNot Yet Recruiting

Clinical Evaluation of a Novel Trifocal IOL

Role: lead

NCT04401982Phase 4Recruiting

Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects

Role: collaborator

NCT07540884Not ApplicableRecruiting

Evaluation of Tears Naturale® Free and Tears Naturale® II Lubricant Eye Drops

Role: lead

NCT06717607Not ApplicableCompleted

Comparing Visual Outcomes in Matched Patients Receiving a Low Cylinder Power Toric IOL or a Non-toric IOL

Role: collaborator

NCT07638943Not ApplicableRecruiting

Refitting Satisfied INFUSE One-Day Multifocal Wearers to DAILIES TOTAL1 Multifocal Contact Lenses

Role: collaborator

NCT07588152Phase 4Recruiting

Imaging the Effects of Netarsudil (Rhopressa) on the Trabecular Meshwork in Glaucoma and Ocular Hypertension

Role: collaborator

NCT07531043Phase 3Not Yet Recruiting

Efficacy and Safety of FID 123472 Ophthalmic Solution for Ocular Redness in Adults

Role: lead

NCT07578363Phase 3Not Yet Recruiting

An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness in Adults

Role: lead

NCT06751225Not ApplicableCompleted

Evaluation of Wear Experience With a Weekly Replacement Soft Contact Lens in Neophyte Lens Wearers With Astigmatism

Role: collaborator

NCT07502456Not ApplicableRecruiting

Clareon TruPlus Study

Role: lead

NCT06401551Not ApplicableCompleted

Clareon PanOptix Pro vs. Clareon PanOptix - Study B

Role: lead

NCT05769153Phase 1Active Not Recruiting

Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Role: lead

NCT06987474Recruiting

Capella Scientia Development Study

Role: lead